New York City Seeks Proposals for $100M Life-Sci "Hub"
The New York City Economic Development Corp. (NYCEDC) has issued a formal request for proposals from companies, institutions, or joint ventures interested in developing a $100 million “Applied Life Sciences Hub” in any of three sites proposed for the project by the public-private agency.
New York Works: NYCEDC Launches Global Challenge to Create New Applied Life Sciences Hub
New York City Economic Development Corporation (NYCEDC) today launched a global challenge to create a world-class hub for life sciences research and development. The “Applied Life Sciences Hub” will be a center of gravity for the city’s rapidly growing life sciences industry, offering a dynamic, collaborative environment for founders, inventors, and entrepreneurs.
Xconomy Award Winner Vicki Sato on How to Build Biotech in New York
Vicki Sato has had a long career helping to lead major biotech businesses in Boston and then teaching Harvard Business School students how to create and grow high-tech companies. So it’s no surprise that when New York City Mayor Bill de Blasio wanted to figure out how replicate Boston’s success in biotech in his city, he tapped Sato for help.
From the Community
Introducing the LifeSci NYC Internship Program
The growth of New York City's life sciences industry depends on attracting and retaining a steady stream of qualified talent to start companies and fill essential roles, especially as New York City's $500 million investment is projected to create 16,000 high-paying jobs in the industry.
From Our Partners
The Silverstein Foundation, REGENXBIO, and OrbiMed Launch Prevail Therapeutics
The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO Inc. (“REGENXBIO”), and OrbiMed today announced the formation and launch of Prevail Therapeutics, Inc., (“Prevail”), a new company focused on discovering and developing novel biologic therapies for Parkinson’s Disease and other neurodegenerative diseases.
From the Community